Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation
Your view on IART
Overview
What the company does, where it operates, and who runs it.
About Integra LifeSciences Holdings Corporation
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Mojdeh Poul
- Headquarters
- 1100 Campus Road, Princeton, NJ, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Mojdeh Poul
- Headquarters
- 1100 Campus Road, Princeton, NJ, US
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies.
The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services.
It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices.
In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair.
Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products.
The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.
Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Integra LifeSciences Holdings Corporation, and the rating behind it. IART last traded at $15.50; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Integra LifeSciences Holdings Corporation. Starting points for Integra LifeSciences Holdings Corporation: EPS -$0.09, beta 1.21 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Integra LifeSciences Holdings Corporation. Integra LifeSciences Holdings Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Integra LifeSciences Holdings Corporation. Trailing twelve-month EPS for Integra LifeSciences Holdings Corporation stands at -$0.09. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Integra LifeSciences Holdings Corporation. Integra LifeSciences Holdings Corporation has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Integra LifeSciences Holdings Corporation valued side by side against its closest peers. Integra LifeSciences Holdings Corporation is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Integra LifeSciences Holdings Corporation, and how their positions are changing. At a $1.21B market value, institutional positions materially move Integra LifeSciences Holdings Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Integra LifeSciences Holdings Corporation executives and directors. Shares of Integra LifeSciences Holdings Corporation have traded between $10.87 and $27.13 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Integra LifeSciences Holdings Corporation. Integra LifeSciences Holdings Corporation is a $1.21B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Integra LifeSciences Holdings Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Integra LifeSciences Holdings Corporation. Coverage tracks Integra LifeSciences Holdings Corporation within Medical - Devices (Healthcare). Press releases and market coverage, newest first.